These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 2556509

  • 1. Protection of murine foot tissue and transplantable tumor against Photofrin-II-mediated photodynamic sensitization with WR-2721.
    Bellnier DA, Dougherty TJ.
    J Photochem Photobiol B; 1989 Nov; 4(2):219-25. PubMed ID: 2556509
    [Abstract] [Full Text] [Related]

  • 2. In vitro and in vivo protection against phototoxic side effects of photodynamic therapy by radioprotective agents WR-2721 and WR-77913.
    Dillon J, Kennedy JC, Pottier RH, Roberts JE.
    Photochem Photobiol; 1988 Aug; 48(2):235-8. PubMed ID: 2851844
    [No Abstract] [Full Text] [Related]

  • 3. Preclinical evaluation of WR-151327: an orally active chemotherapy protector.
    Green D, Bensely D, Schein P.
    Cancer Res; 1994 Feb 01; 54(3):738-41. PubMed ID: 8306335
    [Abstract] [Full Text] [Related]

  • 4. Comparison of the protective effects of three phosphorothioate radioprotectors in the RIF-1 tumor.
    Rasey JS, Krohn KA, Magee S, Nelson N, Chin L.
    Radiat Res; 1986 Nov 01; 108(2):167-75. PubMed ID: 3024202
    [Abstract] [Full Text] [Related]

  • 5. Response of mouse tissues to neutron and gamma radiation: protection by WR-3689 and WR-77913.
    Rasey JS, Magee S, Nelson N, Chin L, Krohn KA.
    Radiother Oncol; 1990 Feb 01; 17(2):167-73. PubMed ID: 2157242
    [Abstract] [Full Text] [Related]

  • 6. Protection of spermatogonial survival and testicular function by WR-2721 against high and low doses of radiation.
    Meistrich ML, Finch MV, Hunter N, Milas L.
    Int J Radiat Oncol Biol Phys; 1984 Nov 01; 10(11):2099-107. PubMed ID: 6092308
    [Abstract] [Full Text] [Related]

  • 7. Modification of the radiation response of the mouse kidney by misonidazole and WR-2721.
    Williams MV, Denekamp J.
    Int J Radiat Oncol Biol Phys; 1983 Nov 01; 9(11):1731-6. PubMed ID: 6315650
    [Abstract] [Full Text] [Related]

  • 8. Radioprotection combined with hypoxic sensitization during radiotherapy of a solid murine tumor.
    Mendiondo OA, Grigsby PW, Beach JL.
    Radiology; 1983 Jul 01; 148(1):291-3. PubMed ID: 6304811
    [Abstract] [Full Text] [Related]

  • 9. Chemical modification of normal tissue damage induced by photodynamic therapy.
    Sigdestad CP, Fingar VH, Wieman TJ, Lindberg RD.
    Br J Cancer Suppl; 1996 Jul 01; 27():S89-92. PubMed ID: 8763855
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selective inhibition of the nephrotoxicity of cis-dichlorodiammineplatinum(II) by WR-2721 without altering its antitumor properties.
    Yuhas JM, Culo F.
    Cancer Treat Rep; 1980 Jan 01; 64(1):57-64. PubMed ID: 6247064
    [Abstract] [Full Text] [Related]

  • 15. Hyperthermic potentiation of photodynamic therapy employing Photofrin I and II: comparison of results using three animal tumor models.
    Waldow SM, Henderson BW, Dougherty TJ.
    Lasers Surg Med; 1987 Jan 01; 7(1):12-22. PubMed ID: 2952850
    [Abstract] [Full Text] [Related]

  • 16. Potentiation of photodynamic therapy in mice with recombinant human tumor necrosis factor-alpha.
    Bellnier DA.
    J Photochem Photobiol B; 1991 Jan 01; 8(2):203-10. PubMed ID: 1828833
    [Abstract] [Full Text] [Related]

  • 17. Radioprotective activity of ethylcellulose microspheres containing WR 2721, after oral administration.
    Fatome M, Courteille F, Laval JD, Roman V.
    Int J Radiat Biol Relat Stud Phys Chem Med; 1987 Jul 01; 52(1):21-9. PubMed ID: 3036725
    [Abstract] [Full Text] [Related]

  • 18. [Studies on the radioprotective effects of YM-08310 (= WR-2721) Part 1: Radioprotective effects of YM-08310 on normal and malignant tissues in mice].
    Tanaka Y, Akagi K, Hasegawa T, Nakazawa M, Harima K, Murata T, Sawada S.
    Nihon Igaku Hoshasen Gakkai Zasshi; 1983 May 25; 43(5):700-9. PubMed ID: 6312407
    [No Abstract] [Full Text] [Related]

  • 19. Rationale for initial clinical trials and future development of radioprotectors.
    Phillips TL.
    Cancer Clin Trials; 1980 May 25; 3(2):165-73. PubMed ID: 6253097
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.